Systematic review of neurokinin-3 receptor antagonists for the management of vasomotor symptoms of menopause
Description
CONCLUSIONS AND RELEVANCE: Because of the high-quality evidence supporting the efficacy of fezolinetant and elinzanetant, these agents may be an effective option with mild adverse events for women seeking nonhormone treatment of VMS.
